Reuters logo
BRIEF-U.S. FDA cleared expanded use of cooling cap, Dignicap cooling system, to reduce hair loss during chemotherapy
July 3, 2017 / 6:18 PM / 3 months ago

BRIEF-U.S. FDA cleared expanded use of cooling cap, Dignicap cooling system, to reduce hair loss during chemotherapy

July 3 (Reuters) - U.S. Food and Drug Administration:

* U.S. Food and Drug Administration - cleared expanded use of cooling cap, dignicap cooling system, to reduce hair loss (alopecia) during chemotherapy Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below